A recent study revealed the possibility of using “EdonPic Maleate” to accelerate recovery and restore movement after the spinal cord injury, as animal experiments showed that the drug improves the ability to control hands and catch things after injury.
This study represents promising progress in developing treatments for spinal cord injuries, which may contribute to improving the quality of patients ’life and reducing the economic and social burdens associated with these injuries.
The study was conducted by researchers from Yokohama City University and from the Nervous Artificial Parties Project at the Tokyo Institute of Medical Sciences in Japan, and its results were published in the “Brain Communications” journal on March 13, and the Yorik Alrt website was written about.
Spinal cord injuries is a health problems that may lead to partial or total paralysis, which affects the lives of millions of people around the world. Despite medical progress, the restoration of motor functions, such as moving the hands, is still a great challenge.
How does Edonerby Maleette work?
Edonebec Malititi enhances nervous flexibility, scientifically known as neurral plasticity, which is the ability of the brain to adapt and reorganize itself after an injury to compensate for lost functions.
Professor Takoya Takahashi, Japanese University of Yokohama and the leader of the research team in this study, says that she focuses on the role of nervous flexibility in recovering from paralysis.
In this study, the researchers used a model of non -human (monkeys) to study the effect of Edonerbey Maleette on kinetic recovery after a partial infection in the cervical spinal cord. Monkeys were trained to capture food using their front ends as part of the experiment. After that, she was caused by a deliberate partial infection in the spinal cord that led to a partial paralysis that loses the ability to perform this task.
Promotion results in restoring movement
The monkeys, after receiving Edonerbey Maleette treatment in conjunction with rehabilitation, showed a noticeable improvement in motor control, especially in its ability to use the affected hand to pick up food.
The results indicated that the drug enhances sending signals between the brain and muscles, which helps to improve movement control. The results also indicated that the drug supports the reshaping of the remaining nerve bonds after the injury, which helps the brain find new paths for movement instead of those that were disrupted due to the injury, thus restoring control of the affected ends.
Brain tests showed that this medicine expands the areas responsible for controlling the movement of the hand, which enhances the ability to make accurate movements such as holding things, indicating that the drug helps the brain adapt to infection faster, and thus speeds up recovery.
“Although this study was conducted on animals, the results are promising and may help in developing a new treatment for humans. We hope this drug will become part of hospital rehabilitation programs, to help patients around the world restore their ability to move,” Professor Takahashi said in this context.